Tag: Anti Viral Drug Remdesivir

drug
COVID-19 Drug: Cipla's Cipremi Set To Cost Less Than Rs 5K Per Vial

New Delhi: Drug maker Cipla Ltd is looking to make the generic version of US-based Gilead Sciences’ anti-viral drug remdesivir available in India in the next 8-10 days and price it less than Rs 5,000 per vial. Gilead Sciences extended a voluntary non-exclusive license to Cipla in May to manufacture and market Cipla’s generic version […]

  • Thursday, 15 April 2021
scrollToTop